Martha Morrell - 24 Mar 2025 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Leah Akin, Attorney-in-Fact
Issuer symbol: NPCE
Transactions as of: 24 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 24 Mar 2025, 18:10:49 UTC
Previous filing: 05 Mar 2025
Next filing: 23 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NPCE	Common Stock	Award	$0	+11,700	+15%	$0.000000	90,926	24 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NPCE	Stock Option (Right to Buy)	Award	$0	+19,850		$0.000000	19,850	24 Mar 2025	Common Stock	19,850	$12.30	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 24, 2026 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
F2	25% of the shares subject to the option vest on March 24, 2026. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.